Penumbra (NYSE:PEN) announced today that it promoted Shruthi Narayan to the position of president of the company. Narayan's appointment goes into effect on Sept. 1, 2025. She continues to report to Adam Elsesser, who previously held the post of president before this promotion. Elsesser continues on as the Penumbra's chair and CEO. The … [Read more...] about Penumbra promotes from within to fill president position
Personnel Moves
Second Heart Assist adds investment firm veteran to board
Second Heart Assist announced that it appointed Bill Carpou to its board of directors as it prepares to scale its cardio-renal platform. Carpou currently serves as CEO of Octane, a leading growth platform for medical technology companies. He previously held a senior operating role with Blackstone, the world's largest alternative investment … [Read more...] about Second Heart Assist adds investment firm veteran to board
InspireMD brings in $58M, adds former Axonics CEO to board
InspireMD (Nasdaq:NSPR) announced today that it raised approximately $58 million and added an experienced executive to its board. In addition to a significant equity private placement (PIPE) financing and warrant exercise, the company appointed Raymond W. Cohen to its board of directors. Cohen brings more than 40 years of leadership experience to … [Read more...] about InspireMD brings in $58M, adds former Axonics CEO to board
Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech (NYSE: JNJ) announced that it has a new chief medical & scientific officer for its Electrophysiology unit. Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role. Michaud, a globally recognized electrophysiologist, … [Read more...] about Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Spectrum Vascular bolsters executive team with new CEO, CCO
Spectrum Vascular announced today that it added to its executive team with the appointment of Ken Miller as CEO and Doug Shook as CCO. The company said its leadership appointments help advance its mission to deliver improved patient outcomes and scale impact. They build upon recent momentum, according to a news release, following a strategic … [Read more...] about Spectrum Vascular bolsters executive team with new CEO, CCO
Xeltis completes enrollment in vascular access conduit study
Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit. The study evaluates aXess in adults with end-stage renal disease. Eindhoven, The Netherlands-based Xeltis will conduct the study in 120 subjects across 22 centers in Europe. This study follows 12-month data from a … [Read more...] about Xeltis completes enrollment in vascular access conduit study
Endologix picks former Medtronic executive as new CEO
Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role. Thompson plans to transition into the position of EVP and chief medical officer. As a result, the company appointed Dr. John Liddicoat as its new president and CEO, effective immediately. Richard Mott, Endologix's board chair, said … [Read more...] about Endologix picks former Medtronic executive as new CEO
Adagio Medical picks medtech veteran Todd Usen as new CEO
Adagio Medical (Nasdaq:ADGM) announced today that it appointed Todd Usen as its new CEO and board director. Usen's appointment follows the departure of Olav Bergheim, the company's founder, CEO and board chair, effective Dec. 13. The company concurrently made Usen CEO and Orly Mishan chair of the board of directors. Bergheim intends to continue … [Read more...] about Adagio Medical picks medtech veteran Todd Usen as new CEO
InspireMD announces CFO retirement, transition
InspireMD announced today that Craig Shore, the company's CFO, decided to retire after the company identifies and appoints a successor. Shore intends to remain as CFO until the stroke prevention company names his replacement to assist in a smooth and orderly transition. He spent 15 years at InspireMD, helping to build the business into "a global … [Read more...] about InspireMD announces CFO retirement, transition
Gradient adds former Edwards exec to board as FDA approves trial expansion
Gradient Denervation Technologies announced today that it appointed medical device entrepreneur and executive Stanton Rowe to its board. Paris-based Gradient also said the FDA approved an expansion of its early feasibility study of its hypertension treatment. The company develops a minimally invasive, ultrasound-based catheter device for … [Read more...] about Gradient adds former Edwards exec to board as FDA approves trial expansion
